Herold Scott Osborne, PA-C

Herold Osborne practices at Wallis Dermatology Associates in Longview, Texas.

Herold Osborne's NPI, 1710999727, was assigned on August 12, 2006. Herold Osborne holds Texas license PA01750.

Herold Osborne's primary practice is Wallis Dermatology Associates, at 3535 4th St, Longview, TX 75605 in Gregg County. The practice phone is (903) 757-3881.

Herold Osborne's primary practice is Wallis Dermatology Associates in Longview, Texas. The medical group on file is U.S. Dermatology Partners. Dmand AI also links Herold Osborne to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Herold Osborne practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Herold Osborne's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Herold Osborne is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Herold Osborne is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, minor head injury and psoriasis among the conditions Herold Osborne treats.

CMS data shows 2,077 Medicare services from Herold Osborne across 15 procedure codes in 2024, for 595 Medicare patients. Medicare paid $71,369 for them. Every service was in an office.

CMS counts 595 Medicare patients who saw Herold Osborne in 2024. The largest group is 65 to 74, with 294 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Herold Osborne's median patient age at 70, with 48% women.

In 2024, Herold Osborne wrote 881 Medicare Part D claims for 351 patients. 93% of them were for generic drugs. CMS names the drug for 786 of them, across 21 drugs with 11 or more claims each, at $321,417 in total drug cost.

Herold Osborne accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 248 general payments to Herold Osborne from 19 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $864.